Canine genomics co. scores $75M in fundingJuly 29, 2021A canine genomics and biotechnology company hoping to increase the lifespan of dogs by three years within the next decade has raised $75 million in Series B funding.
SPONSORED CONTENTTake Control With ProHeart 12 (moxidectin)One dose offers year-long protection with a single injection, putting compliance in your hands. + Learn more
Canine genetics, health to be explored at summitFebruary 9, 2021Preserving and enhancing genetic diversity in dog breeds is set to be explored at an upcoming virtual educational conference.
